RhumbLine Advisers’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-98
| Closed | -$1.48K | – | 4350 |
|
|
2024
Q2 | $1.48K | Sell |
98
-999
| -91% | -$15.1K | ﹤0.01% | 4207 |
|
|
2024
Q1 | $18.2K | Buy |
1,097
+38
| +4% | +$631 | ﹤0.01% | 3775 |
|
|
2023
Q4 | $16.9K | Sell |
1,059
-74
| -7% | -$1.18K | ﹤0.01% | 3794 |
|
|
2023
Q3 | $86.3K | Buy |
1,133
+323
| +40% | +$24.6K | ﹤0.01% | 3506 |
|
|
2023
Q2 | $53.2K | Buy |
+810
| New | +$53.2K | ﹤0.01% | 3667 |
|